维普期刊资源整合服务平台（V6.5）

439篇 您的检索式：作者名="Olanow"

选中清除导出查看参考文献查看引证文献引用追踪共22页首页上一页第1页下一页末页 /22 跳转

	题名	作者	年代	出处	被引量
1	Understanding cell death in parkinson’s disease显示文摘	Peter Jenner C. Warren Olanow	1998	Ann Neurol1998，，1：	2
2	Continuous dopaminergic stimulation in early and advanced Parkinson's disease显示文摘	Stocchi F Olanow CW	2004	Neurology2004，62，：	1
3	An algorithm (decision tree) for the management of Parkinson's disease (2001): Treat- mentGuidelines 显示文摘	Olanow CW Watts RL Koller WC	2001	Neurology2001，56，5：	1
4	Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic and biochemical study显示文摘	OLANOW C W GOOD P F SHINOTOH H	1996	Neurology1996，46，2：	1
5	Defining disease-modifying therapies for PD-a road map for moving forward显示文摘	Olanow C W Kieburtz K	2010	Mov Disord2010，25，12：	1
6	Disease du- ration and the integrity of the nigrostriatal system in Parkinson's disease 显示文摘	Kordower JH Olanow CW Dodiya HB	2013	Brain:a Journal of Neurology2013，136，8：	1
7	Eionlogy and Pathogenesis of Parkin-sons disease显示文摘	Olanow CW Tatton WG	1999	Annu Rev Neurosci1999，22，1：	1
8	Drug insight;Continuous dopaminergic stimulation in the treatment of Parkinson's disease显示文摘	Olanow CW Obesk JA Stacchi F	2006	Clin Nat Pract Neurol2006，2，7：	1
9	Neuropmtective therapy in Parkinson's disease and motor complications search for a pathogenesis targeted, disease-modifying strategy 显示文摘	Olanow C W Jankovic J	2005	Mov Disord2005，20，：	1
10	An Algorithm (decision tree) for the Management of Parkinson's Disease (2001) : Treatment Guidelines显示文摘	OLANOW CW WATTS RL KOLLER WC	2001	Neurology(S0028-3878)2001，56，5：	1
11	Continuous dopamine-receptor treatment of Parkinson' s disease : scientific rationale and clinical implications 显示文摘	Olanow CW Obeso JA Stocchi F	2006	Lancet Neurol2006，5，：	1
12	Levodopa in the treatmem of Parkinson's disease: current controversies 显示文摘	Olanow CW Agid Y Mizuno Y	2004	MovDisord2004，19，9：	1
13	Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson’s disease: an open-label, phase I trial显示文摘	William J Marks Jill L Ostrem Leonard Verhagen Philip A Starr Paul S Larson Roy AE Bakay Robin Taylor Deborah A Cahn-Weiner A Jon Stoessl C Warren Olanow Raymond T Bartus	2008	Lancet Neurology2008，，5：	1
14	The neuropathology of manganese- induced Parkinsonism显示文摘	Perl D P Olanow C W	2007	J Neuropathol Exp Neurol2007，66，8：	1
15	Levodopa: why the controversy显示文摘	Agid Y Olanow CW Mizuno Y	2002	Lancet2002，360，9332：	1
16	Understanding cell death in Parkinson's disease显示文摘	Jenner P Olanow C	1998	Ann Neurol1998，44，：	1
17	An algorithm(decisiontree for themanagement of Parkinson'S disease(2001):treatment guidelines显示文摘	Olanow CW Watts RL Koller WC	2001	Neurology2001，56，115：	1
18	Etiology and pathogenesis ofParkinson、disease显示文摘	OLANOW CW TATTON WG	1999	Annu Rev Neurosci1999，22，1：	1
19	Preventing levodopa-induced dyskinesias显示文摘	Olanow CW Obeso JA	2000	Ann Neurol2000，47，：	1
20	Etiology and pathogenesis of Parkinson's disease显示文摘	Olanow CW Tatton WG	1999	Annu Rev Neurosci1999，22，：	1

返回顶部每页显示：

共22页首页上一页第1页下一页末页 /22 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示